-
1
-
-
10644283057
-
Hypoxia and anemia: Factors in decreased sensitivity to radiation therapy and chemotherapy
-
Harrison L., Blackwell K.: "Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy". Oncologist, 2004, 9 (suppl. 5), 31.
-
(2004)
Oncologist
, vol.9
, Issue.SUPPL. 5
, pp. 31
-
-
Harrison, L.1
Blackwell, K.2
-
2
-
-
35148881028
-
Drug resistance and the solid tumor microenvironment
-
Tredan O., Galmarini C.M., Patel K., Tannock I.F.: "Drug resistance and the solid tumor microenvironment". J. Natl. Cancer Inst., 2007, 99, 1441.
-
(2007)
J. Natl. Cancer Inst.
, vol.99
, pp. 1441
-
-
Tredan, O.1
Galmarini, C.M.2
Patel, K.3
Tannock, I.F.4
-
3
-
-
69049083600
-
Severe hypoxia induces chemoresistance in clinical cervical tumors through MVP over-expression
-
Lara P.C., Lloret M., Clavo B., Apolenario R.M., Henriquez- Hermández L.A., Bordón N. et al.: "Severe hypoxia induces chemoresistance in clinical cervical tumors through MVP over-expression". Radiat. Oncol., 2009, 4, 29.
-
(2009)
Radiat. Oncol.
, vol.4
, pp. 29
-
-
Lara, P.C.1
Lloret, M.2
Clavo, B.3
Apolenario, R.M.4
Henriquez-Hermández, L.A.5
Bordón, N.6
-
4
-
-
33845605116
-
The involvement of hypoxia-inducible factor-1alpha in the susceptibility to gamma-rays and chemotherapeutic drugs of oral squamous cell carcinoma cells
-
Sasabe E., Zhou X., Li D., Oku N., Yamamoto T., Osaki T.: "The involvement of hypoxia-inducible factor-1alpha in the susceptibility to gamma-rays and chemotherapeutic drugs of oral squamous cell carcinoma cells". Int. J. Cancer, 2007, 120, 268.
-
(2007)
Int. J. Cancer
, vol.120
, pp. 268
-
-
Sasabe, E.1
Zhou, X.2
Li, D.3
Oku, N.4
Yamamoto, T.5
Osaki, T.6
-
5
-
-
77957786826
-
Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaB
-
Rohwer N., Dame C., Haugstetter A., Wiedenmann B., Detjen K., Schmitt C.A. Cramer T.: "Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaB". PLOS ONE, 2010, 5, e12038.
-
(2010)
PLOS ONE
, vol.5
-
-
Rohwer, N.1
Dame, C.2
Haugstetter, A.3
Wiedenmann, B.4
Detjen, K.5
Schmitt, C.A.6
Cramer, T.7
-
6
-
-
0038176480
-
Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: Exploring mechanisms of interaction
-
Wachsberger P. BR, Dicker A.P.: "Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction". Clin. Cancer Res., 2003, 9, 1957.
-
(2003)
Clin. Cancer Res.
, vol.9
, pp. 1957
-
-
Wachsberger, P.B.R.1
Dicker, A.P.2
-
7
-
-
0032287342
-
Radiation sensitizing agents for hypoxic cells: Past, present and future
-
Lartigau E: "Radiation sensitizing agents for hypoxic cells: past, present and future". Cancer Radiother., 1998, 2, 775.
-
(1998)
Cancer Radiother.
, vol.2
, pp. 775
-
-
Lartigau, E.1
-
8
-
-
67649347492
-
Radiosensitising agents for the radiotherapy of cancer: Advances in traditional and hypoxia targeted radiosensitisers
-
Bischoff P., Altmeyer A., Dumont F.: "Radiosensitising agents for the radiotherapy of cancer: advances in traditional and hypoxia targeted radiosensitisers". Expert. Opin. Ther. Pat., 2009, 19, 643.
-
(2009)
Expert. Opin. Ther. Pat.
, vol.19
, pp. 643
-
-
Bischoff, P.1
Altmeyer, A.2
Dumont, F.3
-
9
-
-
66449113383
-
Histone acetylation: Where to go and how to get there
-
MacDonald V.E., Howe L.J.: "Histone acetylation: where to go and how to get there". Epigenetics, 2009, 4, 139.
-
(2009)
Epigenetics
, vol.4
, pp. 139
-
-
MacDonald, V.E.1
Howe, L.J.2
-
10
-
-
77952861750
-
Effects of trichostatin A on human lung cancer cell strains A549
-
Zhang D., Liu C.T., Yu X.D., Liu Y.: "Effects of trichostatin A on human lung cancer cell strains A549". Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2010, 32, 167.
-
(2010)
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
, vol.32
, pp. 167
-
-
Zhang, D.1
Liu, C.T.2
Yu, X.D.3
Liu, Y.4
-
11
-
-
33846199978
-
Trichostatin A induces apoptosis in lung cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway
-
Kim H.R., Kim E.J., Yang S.H., Jeong E.T., Park C., Lee J.H. et al.: "Trichostatin A induces apoptosis in lung cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway". Exp. Mol. Med., 2006, 38, 616.
-
(2006)
Exp. Mol. Med.
, vol.38
, pp. 616
-
-
Kim, H.R.1
Kim, E.J.2
Yang, S.H.3
Jeong, E.T.4
Park, C.5
Lee, J.H.6
-
12
-
-
33744749272
-
Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation
-
Piacentini P., Donadelli M., Costanzo C., Moore P.S., Palmieri M., Scarpa A.: "Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation". Virchows Arch., 2006, 448, 797.
-
(2006)
Virchows Arch.
, vol.448
, pp. 797
-
-
Piacentini, P.1
Donadelli, M.2
Costanzo, C.3
Moore, P.S.4
Palmieri, M.5
Scarpa, A.6
-
13
-
-
76749159433
-
The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation
-
Zupkovitz G., Grausenburger R., Brunmeir R., Senese S., Tischler J., Jurkin J. et al.: "The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation". Mol. Cell. Biol., 2010, 30, 1171.
-
(2010)
Mol. Cell. Biol.
, vol.30
, pp. 1171
-
-
Zupkovitz, G.1
Grausenburger, R.2
Brunmeir, R.3
Senese, S.4
Tischler, J.5
Jurkin, J.6
-
14
-
-
0017284850
-
A new antifungal antibiotic, trichostatin
-
Tsuji N., Kobayashi M., Nagashima K., Wakisaka Y., Koizumi K.: "A new antifungal antibiotic, trichostatin". J. Antibiot. (Tokyo), 1976, 29, 1.
-
(1976)
J. Antibiot. (Tokyo)
, vol.29
, pp. 1
-
-
Tsuji, N.1
Kobayashi, M.2
Nagashima, K.3
Wakisaka, Y.4
Koizumi, K.5
-
15
-
-
0034765511
-
Histone deacetylase inhibitors as new cancer drugs
-
Marks P.A., Richon V.M., Breslow R., Rifkind R.A.: "Histone deacetylase inhibitors as new cancer drugs". Curr. Opin. Oncol., 2001, 13, 477.
-
(2001)
Curr. Opin. Oncol.
, vol.13
, pp. 477
-
-
Marks, P.A.1
Richon, V.M.2
Breslow, R.3
Rifkind, R.A.4
-
16
-
-
1642339046
-
The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen
-
Jang E.R., Lim S.J., Lee E.S., Jeong G., Kim T.Y., Bang Y.J., Lee J.S.: "The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen". Oncogene, 2004, 23, 1724.
-
(2004)
Oncogene
, vol.23
, pp. 1724
-
-
Jang, E.R.1
Lim, S.J.2
Lee, E.S.3
Jeong, G.4
Kim, T.Y.5
Bang, Y.J.6
Lee, J.S.7
-
17
-
-
25144451310
-
The histone deacetylase inhibitor, Trichostatin A, enhances radiation sensitivity and accumulation of gammaH2A.X
-
Karagiannis T.C., Harikrishnan K.N., El-Osta A.: "The histone deacetylase inhibitor, Trichostatin A, enhances radiation sensitivity and accumulation of gammaH2A.X". Cancer Biol. Ther., 2005, 4, 787.
-
(2005)
Cancer Biol. Ther.
, vol.4
, pp. 787
-
-
Karagiannis, T.C.1
Harikrishnan, K.N.2
El-Osta, A.3
-
18
-
-
33846625170
-
Inhibition of hypoxia-induced angiogenesis by trichostatin A via suppression of HIF-1a activity in human osteosarcoma
-
Yang Q.C., Zeng B.F., Shi Z.M., Dong Y., Jiang Z.M., Huang J. et al.: "Inhibition of hypoxia-induced angiogenesis by trichostatin A via suppression of HIF-1a activity in human osteosarcoma". J. Exp. Clin. Cancer Res., 2006, 25, 593.
-
(2006)
J. Exp. Clin. Cancer Res.
, vol.25
, pp. 593
-
-
Yang, Q.C.1
Zeng, B.F.2
Shi, Z.M.3
Dong, Y.4
Jiang, Z.M.5
Huang, J.6
-
19
-
-
68149170764
-
Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells
-
Zhang F., Zhang T., Teng Z.H., Zhang R., Wang J.B., Mei Q.B.: "Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells". Cancer Biol. Ther., 2009, 8, 823.
-
(2009)
Cancer Biol. Ther.
, vol.8
, pp. 823
-
-
Zhang, F.1
Zhang, T.2
Teng, Z.H.3
Zhang, R.4
Wang, J.B.5
Mei, Q.B.6
-
20
-
-
0034671806
-
COX-2 is expressed in human pulmonary, colonic, and mammary tumors
-
Soslow R.A., Dannenberg A.J., Rush D., Weener B.M., Khan K.N., Masferrer J., Koki A.T.: "COX-2 is expressed in human pulmonary, colonic, and mammary tumors". Cancer, 2000, 89, 2637.
-
(2000)
Cancer
, vol.89
, pp. 2637
-
-
Soslow, R.A.1
Dannenberg, A.J.2
Rush, D.3
Weener, B.M.4
Khan, K.N.5
Masferrer, J.6
Koki, A.T.7
-
21
-
-
16844362441
-
Histone deacetylation in epigenetics: An attractive target for anticancer therapy
-
Mai A., Massa S., Rotili D., Cerbara I., Valente S., Pezzi R. et al.: "Histone deacetylation in epigenetics: an attractive target for anticancer therapy". Med. Res. Rev., 2005, 25, 261.
-
(2005)
Med. Res. Rev.
, vol.25
, pp. 261
-
-
Mai, A.1
Massa, S.2
Rotili, D.3
Cerbara, I.4
Valente, S.5
Pezzi, R.6
-
22
-
-
14544277978
-
Focus on deacetylation for therapeutic benefit
-
Shabbeer S., Carducci M.A.: "Focus on deacetylation for therapeutic benefit". IDrugs, 2005, 8, 144.
-
(2005)
IDrugs
, vol.8
, pp. 144
-
-
Shabbeer, S.1
Carducci, M.A.2
-
23
-
-
3042618526
-
Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors
-
Zhang Y., Jung M., Dritschilo A., Jung M.: "Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors". Radiat. Res., 2004, 161, 667.
-
(2004)
Radiat. Res.
, vol.161
, pp. 667
-
-
Zhang, Y.1
Jung, M.2
Dritschilo, A.3
Jung, M.4
-
24
-
-
0022366477
-
Enhancement of radiation injury in human colon tumor cells by the maturational agent sodium butyrate (NaB)
-
Arundel C.M., Glicksman A.S., Leith J.T.: "Enhancement of radiation injury in human colon tumor cells by the maturational agent sodium butyrate (NaB)". Radiat. Res., 1985, 104, 443.
-
(1985)
Radiat. Res.
, vol.104
, pp. 443
-
-
Arundel, C.M.1
Glicksman, A.S.2
Leith, J.T.3
-
25
-
-
1642576220
-
Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275
-
Camphausen K., Burgan W., Cerra M., Oswald K.A., Prepel J., Lee M.J., Tofilon P.J.: "Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275". Cancer Res., 2004, 64, 316.
-
(2004)
Cancer Res.
, vol.64
, pp. 316
-
-
Camphausen, K.1
Burgan, W.2
Cerra, M.3
Oswald, K.A.4
Prepel, J.5
Lee, M.J.6
Tofilon, P.J.7
-
26
-
-
14044250159
-
Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid
-
Camphausen K., Cerna D., Scott T., Sproull M, Burgan W.E., Cerra M.A. et al.: "Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid". Int. J. Cancer, 2005, 114, 380.
-
(2005)
Int. J. Cancer
, vol.114
, pp. 380
-
-
Camphausen, K.1
Cerna, D.2
Scott, T.3
Sproull, M.4
Burgan, W.E.5
Cerra, M.A.6
-
27
-
-
34748877735
-
Inhibition of histone deacetylation: A strategy for tumor radiosensitization
-
Camphausen K., Tofilon P.J.: "Inhibition of histone deacetylation: a strategy for tumor radiosensitization". J. Clin. Oncol., 2007, 25, 4051.
-
(2007)
J. Clin. Oncol.
, vol.25
, pp. 4051
-
-
Camphausen, K.1
Tofilon, P.J.2
-
28
-
-
17844381019
-
Modulation of radiation response by histone deacetylase inhibition
-
Chinnaiyan P., Vallabhaneni G., Armstrong E., Huang S.M., Harari P.M.: "Modulation of radiation response by histone deacetylase inhibition". Int. J. Radiat. Oncol. Biol. Phys., 2005, 62, 223.
-
(2005)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.62
, pp. 223
-
-
Chinnaiyan, P.1
Vallabhaneni, G.2
Armstrong, E.3
Huang, S.M.4
Harari, P.M.5
-
29
-
-
4444278103
-
Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy
-
Chung Y.L., Wang A.J., Yao L.F.: "Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy". Mol. Cancer Ther., 2004, 3, 317.
-
(2004)
Mol. Cancer Ther.
, vol.3
, pp. 317
-
-
Chung, Y.L.1
Wang, A.J.2
Yao, L.F.3
-
30
-
-
16644389497
-
Histone deacetylase inhibitors are potent radiation protectants
-
Paoluzzi L., Figg W.D.: "Histone deacetylase inhibitors are potent radiation protectants". Cancer Biol. Ther., 2004, 3, 612.
-
(2004)
Cancer Biol. Ther.
, vol.3
, pp. 612
-
-
Paoluzzi, L.1
Figg, W.D.2
-
31
-
-
68149170764
-
Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells
-
Zhang F., Zhang T., Teng Z.H., Zhang R., Wang J.B., Mei Q.B.: "Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells". Cancer Biol. Ther., 2009, 8, 823.
-
(2009)
Cancer Biol. Ther.
, vol.8
, pp. 823
-
-
Zhang, F.1
Zhang, T.2
Teng, Z.H.3
Zhang, R.4
Wang, J.B.5
Mei, Q.B.6
-
32
-
-
0035048449
-
Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes
-
Kim M.S., Kwon H.J., Lee Y.M., Baek J.H., Jang J.E., Lee S.W. et al.: "Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes". Nat. Med., 2001, 7, 437.
-
(2001)
Nat. Med.
, vol.7
, pp. 437
-
-
Kim, M.S.1
Kwon, H.J.2
Lee, Y.M.3
Baek, J.H.4
Jang, J.E.5
Lee, S.W.6
-
33
-
-
85047699941
-
Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling
-
Deroanne C.F., Bonjean K., Servotte S., Devy L., Colige A., Clausse N. et al.: "Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling". Oncogene, 2002, 21, 427.
-
(2002)
Oncogene
, vol.21
, pp. 427
-
-
Deroanne, C.F.1
Bonjean, K.2
Servotte, S.3
Devy, L.4
Colige, A.5
Clausse, N.6
|